test

Flynn Management LLC, its general partner

@Deerfield Management Company, L.p. (series C)

Latest period2024 - Q3ReportedManaged Assets$6.693BTotal holdings443
Assets growth rate11.36%Assets growth rate (2-Q avg)7.96%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Deerfield Management Company, L.p. (series C)'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 443 positions.

Assets under management

The assets under management (AUM) of Deerfield Management Company, L.p. (series C) over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.693B in assets, with a quarterly growth rate of 11.36% and a 2-quarter average growth rate of 7.96%. The portfolio is managed by Flynn Management LLC, its general partner, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IDYAIdeaya Biosciences Inc
Recent Activity
Increased 23.7%
1.23%
$82.178M
2.594M shares@ $31.68 avg price
OMIOwens & Minor Inc New
Recent Activity
Decreased -22.9%
1.16%
$77.069M
4.912M shares@ $15.7 avg price
BAXBaxter Intl Inc
Recent Activity
Increased 21.9%
1.1%
$73.02M
1.923M shares@ $37.97 avg price
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
0.93%
$61.832M
8.136M shares@ $7.6 avg price
SGRYSurgery Partners Inc
Recent Activity
Decreased -62.18%
0.86%
$57.396M
1.78M shares@ $32.25 avg price
CVSCvs Health Corp
Recent Activity
Decreased -10.27%
0.83%
$55.007M
874,800 shares@ $62.88 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
Decreased 0%
0.83%
$54.907M
3.28M shares@ $16.74 avg price
BIOBio Rad Labs Inc
Recent Activity
Decreased -0.09%
0.76%
$50.714M
151,575 shares@ $334.59 avg price
IRONDisc Medicine Inc
Recent Activity
0.76%
$50.283M
1.023M shares@ $49.14 avg price
INDVIndivior Plc
Recent Activity
New Position
0.75%
$49.653M
5.093M shares@ $9.76 avg price